This experiment aimed to examine endocrine and metabolic responses to glucose, insulin, and adrenocorticotropin (ACTH) infusions in early-lactation dairy goats of different levels of milk production (LMP). Goats were grouped as either high (HY; 4.0 L/d, n = 13) or low milk yield (LY; 2.4 L/d, n = 13). Individual milk yield (L/d) and dry matter intake (DMI; kg/d) were measured daily. Concentration (mM) of glucose, fatty acids, and β-hydroxybutyrate, percent of milk fat and protein, body weight (BW; kg), and body condition score (BCS) were assessed weekly (from 2-6 wk postpartum). An intravenous glucose tolerance test (IVGTT), an insulin tolerance test (ITT), and an ACTH stimulation test were carried out at 43, 44, and 45 ± 0.7 d in milk, respectively. The HY goats had greater milk yield (+67%), energy-corrected milk (ECM; +70%), DMI (+28%), ratio of ECM output to metabolic BW (+67%), and feed efficiency (+25%), but lesser BCS than LY goats (2.4 vs. 2.6). The DMI (% of BW) was moderately correlated with ECM (r = 0.70) and negatively correlated with BCS (r = −0.57). At the time of the IVGTT, HY goats had lesser basal insulin and glucose than LY goats. However, results from IVGTT and ITT indicate that the sensitivity of peripheral tissues to insulin was unaffected by LMP. Compared with LY, HY goats had lesser insulin secretion (−52%) and greater insulin clearance rate (+47%) after glucose infusion. The ITT and ACTH stimulation test results show that both the growth hormone response to insulin and the cortisol response to ACTH were unaffected by LMP. Also, basal plasma concentrations of GH and cortisol were not correlated with glucose and fatty acids concentrations or any performance traits. Collectively, our results suggest that differences between HY and LY goats, concerning milk yield and feed efficiency, were probably more closely related to differences in insulin secretion and clearance than to differences in peripheral tissue responsiveness to the effects of catabolic and anabolic hormones.
The aim of this observational study was to identify the influence of key nongenetic factors such as month of kidding, parity, and litter size on milk yield and composition of Australian dairy goats throughout lactation. The study was conducted over 4 consecutive kidding seasons from June 2016 to March 2017. Data from 940 lactations of Saanen goats from a commercial herd were used to observe the effects of month of kidding, parity number, and litter size on total milk yield (L/goat) in early lactation (kidding to 90 d in milk; DIM), mid lactation (91-180 DIM), and late lactation (181-270 DIM), cumulative milk yield (from kidding to 270 DIM; CMY), average lactation length, proportion (%) of does reaching their target lactation length (270 DIM), somatic cell count (SCC), and percentages of milk fat and protein in early lactation. The mean herd responses throughout the entire study were as follows: CMY = 519 L/goat; lactation length = 233 d, with 70% of does reaching 270 DIM; milk fat = 4.2%; milk protein = 2.9%; and SCC = 6.2 × 10 5 cells/mL. Average milk production peaked in February and was lowest in June (2.4 vs. 1.8 L/goat per day, respectively). Milk yield was affected by month of kidding, parity number, and litter size in all phases of lactation. November kidders had the greatest CMY, and March kidders had the lowest CMY. March kidders had the shortest lactation length and the lowest proportion of does reaching 270 DIM. June kidders had the longest lactation length, whereas September kidders had the highest proportion of does reaching 270 DIM. Maximum milk yield was attained in third parity. Goats in fourth or greater parity had the shortest lactation length, the lowest proportion of does reaching 270 DIM, and the highest SCC. Goats delivering single kids had lower CMY, lower SCC, and higher percentages of fat and protein than does deliv-ering multiple kids. Our findings indicate that milk yield was primarily influenced by month of kidding, and the effects of month of kidding on milk yield were accentuated during mid lactation. However, the effects of month of kidding on milk yield varied significantly among parities.
The aim of this study was to evaluate temporal variations in circulating levels of selected hormones and metabolites in commercial dairy goats during the transition period. Blood samples from 940 goats were collected weekly, from −3 to 3 wk relative to delivery, to measure the effects of level of milk production, parity number, and litter size on concentrations of glucose, β-hydroxybutyrate (BHB), fatty acids, and plasma urea nitrogen (PUN). A subset of 80 goats [40 low-yielding (LY, < 1.8 L/d) and 40 high-yielding goats (HY, > 3.7 L/d)] were selected from the study population to measure the effects of level of milk production on plasma concentration of insulin, prolactin, and growth hormone. Average (±SD) milk yield (from 3 to 30 d in milk), body weight, and body condition score for the study population were 2.4 ± 0.78 L/d, 70 ± 16.0 kg, and 2.5 ± 0.28 units, respectively. Milk yield was moderately correlated with parity number (r = 0.49) but had weak correlation with litter size (r = 0.14). In multiparous but not in primiparous goats, antepartum concentrations of fatty acids and BHB increased with increasing litter size. Concentrations of fatty acids, BHB, and PUN were consistently lower in primiparous goats compared with those in second or greater parity. Postpartum, HY goats had higher ratios of glucose, fatty acids, and BHB to insulin than did LY goats, which might explain the greater mobilization of body tissues and enhanced milk production observed in this group. Collectively, our results indicate that increased milk yield has the most significant influence on the magnitude of body tissue mobilization. Our results also show that goats of higher parity display higher levels of lipid mobilization, and that both pregnancy and lactation are less able to elicit lipomobilization in primiparous compared with multiparous goats.
BackgroundThis was a panel study of the prevalence of C. burnetii infection in does in an endemic dairy goat enterprise in Victoria, Australia. Our first objective was to determine the prevalence of does shedding C. burnetii at the time of parturition and to quantify the concentration of genome equivalents (GE) present in each C. burnetii positive sample. Our second objective was to determine the proportion of positive does that were persistent shedders. Our final objective was to quantify the association between C. burnetii qPCR status at the time of kidding and daily milk volumes produced during the subsequent lactation.ResultsVaginal swabs (n= 490) were collected from does at the time of kidding and analysed using a quantitative polymerase chain reaction (qPCR) assay. Shedding of C. burnetii was detected in 15% (95% CI: 12% to 18%) of the sampled does. Does were classified as qPCR-negative, qPCR-positive low and qPCR-positive high based on the estimated concentration of GE from the qPCR. Persistent shedding at relatively low concentrations was detected in 20% (95% CI: 10% to35%) of shedding does sampled again at their subsequent parturition. After controlling for possible confounders and adjusting for variation in daily milk yields at the individual doe level, daily milk yields for qPCR-positive high does were reduced by 17% (95% CI: 3% to 32%) compared to qPCR-negative does (p= 0.02).ConclusionsShedding concentrations of C. burnetii were highly skewed, with a relatively small group of does shedding relatively high quantities of C. burnetii. Further, high shedding does had reduced milk yields compared to qPCR-negative does. Early detection and culling of high shedding does would result in increased farm profitability and reduce the risk of Q fever transmission.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.